GlassScriptPhysician profile
Todd C Lewis
NPI 1245274505
$25,208.52
in general payments reported to CMS, 2019-2025
63 companies · $2,381 in 2025
The $2,381 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,251 · 2020: $2,601 · 2021: $3,894 · 2022: $2,844 · 2023: $4,196 · 2024: $7,041 · 2025: $2,381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $2,480 · Travel and Lodging: $445 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,593.75 |
| Consulting Fee | $2,480.00 |
| Travel and Lodging | $445.38 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,092.26 | 2019-2025 | |
| Cardiovascular Systems INC. | $2,479.28 | 2019-2023 | Diamondback Peripheral, Diamondback Coronary |
| Janssen Pharmaceuticals, INC | $1,515.63 | 2019-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $1,345.06 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Abiomed | $1,231.33 | 2019-2024 | Impella |
| Shockwave Medical, INC | $1,134.28 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave M5+ |
| Pfizer INC. | $1,102.65 | 2019-2025 | |
| United Therapeutics Corporation | $1,034.42 | 2021-2025 | Tyvaso, Tyvaso, Orenitram |
| Amgen INC. | $995.28 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $984.00 | 2019-2024 | Mitraclip, Diamondback Peripheral, Xience Sierra |
| Boston Scientific Corporation | $859.10 | 2019-2025 | Hornet 10, Watchman Flx, Rotapro |
| Medtronic, INC. | $767.19 | 2021-2025 | Onyx Frontier, Abre, Hawkone |
| Merck Sharp & Dohme LLC | $759.10 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $710.02 | 2020-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $614.95 | 2019-2025 | Jardiance |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $571.01 | 2019-2025 | Farxiga |
| Esperion Therapeutics, INC. | $382.73 | 2020-2025 | Nexletol |
| Angiodynamics, INC. | $356.74 | 2023-2025 | Auryon Laser System 100-120 Vac |
| Novo Nordisk INC | $342.97 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Penumbra, INC. | $277.55 | 2019-2025 | Penumbra System, Indigo System, Ruby Coil |
| Astellas Pharma US INC | $243.17 | 2019-2021 | |
| Biotronik INC. | $239.12 | 2020-2022 | |
| Arteriocyte Medical Systems, INC. | $237.46 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $224.25 | 2019-2021 | |
| Amarin Pharma, INC. | $220.87 | 2019-2021 | |
| Ge Healthcare | $218.20 | 2022-2023 | |
| Integra Lifesciences Corporation | $205.35 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medtronic Vascular, INC. | $178.31 | 2019-2020 | |
| Stryker Corporation | $156.78 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $130.78 | 2023 | Sapien 3 Ultra Resilia |
| Chiesi USA, INC. | $113.82 | 2019-2023 | Cleviprex, Kengreal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $112.17 | 2019-2025 | Lifevest |
| Cms Imaging, INC. | $106.00 | 2022 | |
| Philips North America LLC | $105.26 | 2020-2023 | |
| E.R. Squibb & Sons, L.L.C. | $99.96 | 2021-2023 | Camzyos |
| Baxter Healthcare | $88.82 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $80.32 | 2019 | |
| Avinger INC. | $77.48 | 2021 | |
| Bard Peripheral Vascular, INC. | $74.58 | 2021-2023 | Venclose Maven Catheter |
| Cardiva Medical, INC. | $68.14 | 2021-2022 | |
| Scpharmaceuticals INC. | $68.01 | 2025 | |
| Acist Medical Systems, INC. | $64.95 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $59.35 | 2021-2025 | Amvuttra |
| Daiichi Sankyo INC. | $48.67 | 2025 | Injectafer |
| Kiniksa Pharmaceuticals, LTD. | $46.48 | 2022-2023 | Arcalyst |
| Teleflex LLC | $45.14 | 2023-2025 | Vascband, Turnpike |
| Genzyme Corporation | $41.38 | 2022-2023 | |
| Recor Medical INC | $33.01 | 2025 | Paradise Ultrasound Renal Denervation System |
| Irhythm Technologies, INC. | $31.83 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Johnson & Johnson Health Care Systems INC. | $30.52 | 2023 | Uptravi, Opsumit |
| Kiniksa Pharmaceuticals International, Plc | $29.50 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $28.94 | 2025 | Inspire |
| Celgene Corporation | $26.64 | 2025 | Eliquis |
| Bardy Diagnostics, INC. | $25.50 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $17.84 | 2024 | |
| Livanova USA, INC. | $17.15 | 2023 | Lifesparc |
| Lilly USA, LLC | $15.75 | 2025 | Mounjaro |
| Glaxosmithkline, LLC. | $15.52 | 2025 | Arexvy, Shingrix |
| Kestra Medical Technology Services, INC. | $14.69 | 2025 | Assure Wcd |
| Terumo Medical Corporation | $11.26 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.